AbbVie ABBV Treasury Stock, Value
Treasury Stock, Value at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's treasury stock, value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbbVie's treasury stock, value?
- AbbVie (ABBV) reported treasury stock, value of $10.61B in Q1 2026.
- How has AbbVie's treasury stock, value changed year-over-year?
- AbbVie's treasury stock, value increased by 16.1% year-over-year, from $9.14B to $10.61B.
- What is the long-term trend for AbbVie's treasury stock, value?
- Over 5 years (2020 to 2025), AbbVie's treasury stock, value has grown at a 32.2% compound annual growth rate (CAGR), from $2.26B to $9.15B.
- What does treasury stock, value mean?
- This represents the cost of common shares that the company has repurchased from the open market and holds in its treasury. Treasury stock reduces total shareholders' equity and is often used for employee stock compensation plans or to return capital to shareholders. It is recorded as a contra-equity account.